Evidence map›Paper›PMID 35341660›Full record

ArticleAmerican journal of infection control2022

A task analysis of central line-associated bloodstream infection (CLABSI) surveillance in home infusion therapy.

Susan M Hannum, Opeyemi Oladapo-Shittu, Alejandra B Salinas, Kimberly Weems, Jill Marsteller, Ayse P Gurses, Sara E Cosgrove, Sara C Keller

Open access · greenAbstract read
In one paragraph

Article in American journal of infection control, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. CLABSIs aren't just for inpatients: the need to identify CLABSI burden among outpatients.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Susan M HannumDepartment of Health Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Opeyemi Oladapo-ShittuDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Alejandra B SalinasDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Kimberly WeemsDepartment of Hospital Epidemiology and Infection Control, Johns Hopkins Hospital, Baltimore, MD.
Jill MarstellerDepartment of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Armstrong Institute of Patient Safety and Quality, Johns Hopkins University School of Medicine, Baltimore, MD.
Ayse P GursesArmstrong Institute of Patient Safety and Quality, Johns Hopkins University School of Medicine, Baltimore, MD.
Sara E CosgroveDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Hospital Epidemiology and Infection Control, Johns Hopkins Hospital, Baltimore, MD; Armstrong Institute of Patient Safety and Quality, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Sara C KellerDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Armstrong Institute of Patient Safety and Quality, Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: skeller9@jhmi.edu.
Johns Hopkins University · USJohns Hopkins Hospital · US

Funding

The Home Infusion Collaborative to Eliminate Central Line-Associated Bloodstream Infections (CLABSI)R01HS027819 · AHRQ · JOHNS HOPKINS UNIVERSITY · PI KELLER, SARA CONDRON · 2020 to 2024
$2.5M
AHRQ HHS R01 HS027819
6 · The paper itself

Abstract

backgroundBarriers for home infusion therapy central line associated bloodstream infection (CLABSI) surveillance have not been elucidated and are needed to identify how to support home infusion CLABSI surveillance. We aimed to (1) perform a goal-directed task analysis of home infusion CLABSI surveillance, and (2) describe barriers to, facilitators for, and suggested strategies for successful home infusion CLABSI surveillance.

methodsWe conducted semi-structured interviews with team members involved in CLABSI surveillance at 5 large home infusion agencies to explore work systems used by members of the agency for home infusion CLABSI surveillance. We analyzed the transcribed interviews qualitatively for themes.

resultsTwenty-one interviews revealed 8 steps for performing CLABSI surveillance in home infusion therapy. Major barriers identified included the need for training of the surveillance staff, lack of a standardized definition, inadequate information technology support, struggles communicating with hospitals, inadequate time, and insufficient clinician engagement and leadership support. DISCUSSION: Staff performing home infusion CLABSI surveillance need health system resources, particularly leadership and front-line engagement, access to data, information technology support, training, dedicated time, and reports to perform tasks.

conclusionsBuilding home infusion CLABSI surveillance programs will require support from home infusion leadership.

Indexed as

Catheterization, Central VenousCatheter-Related InfectionsCross InfectionHome Infusion TherapySepsisHumansLeadershipambulatory careCentral venous catheterHealth care associated infectionhuman factors engineeringinfection preventionist

Identifiers

PMID35341660
PMCPMC10184038
OpenAlexW4221012484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.